Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10208-10214
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10208
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10208
Table 1 Clinical characteristics of patients n (%)
| Characteristics | All patients (n = 42) |
| Sex | |
| Male | 30 (71) |
| Female | 12 (29) |
| Age (yr), median | 31.9 (17-57) |
| Disease duration (yr), median | 6.2 (0-16) |
| Disease type | |
| Ileal | 11 (26) |
| Ileo-colonic | 26 (62) |
| Colonic | 5 (12) |
| Patients with concomitant medication | |
| 5-aminosalicylic acid | 41 (98) |
| Prednisone | 9 (21) |
| Azathioprine | 7 (17) |
| Enteral nutrition | 24 (57) |
| Previous segmental resection | 8 (19) |
| Infliximab | 10 (24) |
| Adalimumab | 32 (76) |
- Citation: Yamamoto K, Chiba T, Matsumoto T. Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn’s disease. World J Gastroenterol 2015; 21(35): 10208-10214
- URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10208.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10208